港股异动 | 申洲国际低开4.81% 遭大股东减持
格隆汇9月20日丨申洲国际(2313.HK)低开4.81%,报103港元,暂成交32.4亿港元,最新总市值1548.3亿港元。申洲国际今晨公布,于9月20日(即今日),卖方与经办人订立次级大宗交易协议,以向专业、机构、企业或其他投资者买卖股份,购买价为每股102港元。大股东协荣及管理层持有的富高集团,将根据出售事项分别出售27,979,750股及3,720,250股股份,出售事项预期于9月24日完成,协荣及富高持申洲国际已发行股份分別降至约44.76%及约5.04%。此前大摩曾发研报将申洲目标价由120港元升至140港元,并且不排除至2022年底股价升至200港元,评级重申“增持”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.